Zhejiang Medicine Co., Ltd. (600216.SS)
CNY 16.02
(0.5%)
CNY 16.02
(0.5%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 634.31 Million | 520.6 Million | 1.13 Billion | 1.25 Billion | 447.24 Million | 579.9 Million |
| Net Income | 276.79 Million | 362.61 Million | 884.55 Million | 659.64 Million | 291.95 Million | 327.2 Million |
| Depreciation & Amortization | 724.97 Million | 681.6 Million | 587.56 Million | 503.8 Million | 487.73 Million | 428.89 Million |
| Deferred income taxes | -6.93 Million | -16.52 Million | 17.17 Million | -21.67 Million | -3.64 Million | -5.29 Million |
| Stock-based compensation | 37.46 Million | 33.29 Million | 42.23 Million | 1.19 Million | 6.38 Million | 21.85 Million |
| Change in working capital | -198.39 Million | -727.26 Million | -568.09 Million | -5.6 Million | -360.59 Million | -344.09 Million |
| Other non-cash items | -5.56 Million | 186.87 Million | 173.21 Million | 119.35 Million | 25.41 Million | 167.89 Million |
| Investing Cash Flow | -518.59 Million | -971.15 Million | -983.69 Million | -237.72 Million | -618.19 Million | -464.8 Million |
| Investments in PPE | -796.86 Million | -975.99 Million | -939.6 Million | -535.34 Million | -573.62 Million | -439.3 Million |
| Acquisitions | 228.93 Million | 9.12 Million | -140.72 Million | 27.43 Million | 2.42 Million | -27.19 Million |
| Investment purchases | -208.75 Million | -357.38 Million | -281.86 Million | -325.66 Million | -214.52 Million | -104.13 Million |
| Sales/Maturities of investments | 192.56 Million | 440.25 Million | 320.89 Million | 454.05 Million | 177.97 Million | 35.04 Million |
| Other Investing Activities | 119.98 Million | -87.16 Million | 57.6 Million | 141.8 Million | -10.43 Million | 70.77 Million |
| Financing Cash Flow | -141.42 Million | 43.91 Million | 69.75 Million | -627.47 Million | -62.6 Million | -42.45 Million |
| Debt repayment | -341.91 Thousand | -65.46 Million | -700.11 Million | -1.09 Billion | -545.09 Million | -434.1 Million |
| Dividends payments | -163.99 Million | -318.49 Million | -220.4 Million | -1 Billion | -143.72 Million | -98.05 Million |
| Common Stock Repurchased | -1.29 Million | - | - | - | -39.53 Million | -23.64 Million |
| Common Stock Issuance | - | - | - | - | 39.53 Million | - |
| Other Financing Activities | 52.41 Million | 460.47 Million | 1.02 Billion | 1.47 Billion | 650.48 Million | 489.69 Million |
| Accounts receivables | -29.42 Million | -161.98 Million | -402.19 Million | 76.5 Million | -172.79 Million | 4.79 Million |
| Accounts payables | 101.69 Million | -218.04 Million | 577.5 Million | 154.67 Million | 230.61 Million | 39.38 Million |
| Inventory | -263.72 Million | -330.7 Million | -760.57 Million | -215.1 Million | -414.77 Million | -382.96 Million |
| Other working capital | 37.46 Million | -16.52 Million | 17.17 Million | -21.67 Million | -3.64 Million | 38.87 Million |
| Cash at beginning of period | 1.43 Billion | 1.76 Billion | 1.62 Billion | 1.27 Billion | 1.49 Billion | 1.41 Billion |
| Cash at end of period | 1.45 Billion | 1.43 Billion | 1.76 Billion | 1.62 Billion | 1.27 Billion | 1.49 Billion |
| Capital Expenditure | -796.86 Million | -975.99 Million | -939.6 Million | -535.34 Million | -573.62 Million | -439.3 Million |
| Effect of forex changes on cash | 47.64 Million | 76.01 Million | -79.83 Million | -42.7 Million | 19.52 Million | 3.7 Million |
| Net cash flow / Change in cash | 21.93 Million | -330.62 Million | 142.87 Million | 348.82 Million | -214.01 Million | 76.35 Million |
| Free Cash Flow | -162.55 Million | -455.38 Million | 197.05 Million | 721.37 Million | -126.38 Million | 140.6 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 534.31 Million | 205.68 Million | 109.64 Million | 276.79 Million | 128.3 Million | 29.07 Million |
| Depreciation & Amortization | - | 180.69 Million | 180.69 Million | 724.97 Million | 185.49 Million | -323.94 Million |
| Deferred income taxes | - | - | - | -6.93 Million | - | 291.5 Million |
| Stock-based compensation | - | 8.5 Million | - | 37.46 Million | 37.46 Million | -45.05 Million |
| Change in working capital | - | -412.17 Million | - | -198.39 Million | -255.68 Million | 77.28 Million |
| Other non-cash items | -49.91 Million | 161.73 Million | -86.47 Million | -5.56 Million | 280.43 Million | 129.37 Million |
| Investing Cash Flow | -115.56 Million | -226.14 Million | 57.77 Million | -518.59 Million | -139.12 Million | -137.87 Million |
| Investments in PPE | -149.63 Million | -153.5 Million | -170.59 Million | -796.86 Million | -158.96 Million | -173.73 Million |
| Acquisitions | -855.58 Thousand | 918.05 Thousand | 193.91 Million | 228.93 Million | -2.21 Million | -1.1 Million |
| Investment purchases | -73.55 Million | -412.2 Million | -122.25 Million | -208.75 Million | -75.22 Million | -14.77 Million |
| Sales/Maturities of investments | 70.35 Million | 369.72 Million | 125.63 Million | 192.56 Million | 48.64 Million | 25.45 Million |
| Other Investing Activities | 37.27 Million | 120 Million | 31.07 Million | 119.98 Million | 48.03 Million | 26.27 Million |
| Financing Cash Flow | -202.49 Million | -87.88 Million | 43.27 Million | -141.42 Million | -7.79 Million | -170.77 Million |
| Debt repayment | -52 Million | -50 Million | -50 Million | -341.91 Thousand | -200 Million | -100 Million |
| Dividends payments | -150.49 Million | -8.71 Million | -6.72 Million | -163.99 Million | -5.01 Million | -170.65 Million |
| Common Stock Repurchased | 29 Million | -29 Million | - | -1.29 Million | -1.29 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -231.69 Million | -8.71 Million | -6.72 Million | 52.41 Million | -842.91 Thousand | 99.87 Million |
| Accounts receivables | - | -353.68 Million | - | -29.42 Million | -29.42 Million | -90.75 Million |
| Accounts payables | - | - | - | 101.69 Million | - | - |
| Inventory | - | -58.49 Million | - | -263.72 Million | -263.72 Million | 168.04 Million |
| Other working capital | - | - | - | 37.46 Million | 37.46 Million | - |
| Cash at beginning of period | 1.46 Billion | 1.58 Billion | 1.45 Billion | 1.43 Billion | 1.34 Billion | 1.5 Billion |
| Cash at end of period | 1.63 Billion | 1.46 Billion | 1.58 Billion | 1.45 Billion | 1.45 Billion | 1.34 Billion |
| Capital Expenditure | -149.63 Million | -153.5 Million | -170.59 Million | -796.86 Million | -158.96 Million | -173.73 Million |
| Effect of forex changes on cash | 2.25 Million | 11.84 Million | 44.68 Thousand | 47.64 Million | 33.59 Million | -7.55 Million |
| Net cash flow / Change in cash | 166.87 Million | -115.45 Million | 124.26 Million | 21.93 Million | 110.28 Million | -157.97 Million |
| Free Cash Flow | 334.77 Million | 33.21 Million | -147.42 Million | -162.55 Million | 64.26 Million | -15.48 Million |
FLEW
GAME
600829
2314
ELISA
688256